These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10830241)

  • 1. Tacrolimus and myocardial hypertrophy.
    Nakata Y; Yoshibayashi M; Yonemura T; Uemoto S; Inomata Y; Tanaka K; Furusho K
    Transplantation; 2000 May; 69(9):1960-2. PubMed ID: 10830241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report.
    Mano A; Nakatani T; Yahata Y; Kato T; Hashimoto S; Wada K; Ishibashi-Ueda H
    Transplant Proc; 2009 Nov; 41(9):3831-4. PubMed ID: 19917396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A?
    Hudnall SD
    Transplantation; 2002 Sep; 74(6):757-8. PubMed ID: 12369583
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both?
    Therapondos G; Plevris JN; Dollinger MM; Hayes PC; Flapan AD
    Transplantation; 2003 Jul; 76(2):446-7; author reply 447-8. PubMed ID: 12883220
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.
    Turska-Kmieć A; Jankowska I; Pawłowska J; Kaliciński P; Kawalec W; Tomyn M; Markiewicz M; Teisseyre J; Czubkowski P; Rekawek J; Socha J
    Pediatr Transplant; 2007 May; 11(3):319-23. PubMed ID: 17430490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.
    Liu T; Gao Y; Gao YL; Cheng YT; Wang S; Li ZZ; Zhang HB; Meng X; Ma CS; Dong JZ
    Chin Med J (Engl); 2012 Apr; 125(7):1352-4. PubMed ID: 22613615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation.
    Chang RK; Alzona M; Alejos J; Jue K; McDiarmid SV
    Am J Cardiol; 1998 May; 81(10):1277-80. PubMed ID: 9604971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant.
    Roberts CA; Stern DL; Radio SJ
    Transplantation; 2002 Sep; 74(6):817-21. PubMed ID: 12364862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.
    Dehghani SM; Haghighat M; Imanieh MH; Zahmatkeshan M; Borzooei M; Amoozegar H; Zamirian M; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Malek-Hosseini SA
    Arch Iran Med; 2010 Mar; 13(2):116-9. PubMed ID: 20187665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver due to high levels of serum tacrolimus after liver transplantation.
    Tümgör G; Ankan C; Nart D; Kihiç M; Aydoğdu S
    Turk J Pediatr; 2007; 49(2):223-5. PubMed ID: 17907528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients.
    Atkison P; Joubert G; Barron A; Grant D; Paradis K; Seidman E; Wall W; Rosenberg H; Howard J; Williams S
    Lancet; 1995 Apr; 345(8954):894-6. PubMed ID: 7535875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of tacrolimus in pediatric liver transplantation.
    McDiarmid SV
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):90-102. PubMed ID: 9443127
    [No Abstract]   [Full Text] [Related]  

  • 13. Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression.
    Lykavieris P; Frauger E; Habes D; Bernard O; Debray D
    Transplantation; 2003 Jan; 75(1):152-55. PubMed ID: 12544888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation.
    Shen T; Feng XW; Geng L; Zheng SS
    World J Gastroenterol; 2015 May; 21(20):6422-6. PubMed ID: 26034381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
    Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictable and Unusual Adverse Effects of Immunosuppression in Pediatric Liver Transplant Patients.
    Öztürk H; Ekşi Bozbulut N; Sarı S; Eğritaş Gürkan Ö; Sözen H; Sapmaz A; Dalgıç A; Dalgıç B
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):230-233. PubMed ID: 30777562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene.
    Yamauchi A; Ieiri I; Kataoka Y; Tanabe M; Nishizaki T; Oishi R; Higuchi S; Otsubo K; Sugimachi K
    Transplantation; 2002 Aug; 74(4):571-2. PubMed ID: 12352921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G; Arikan C; Kilic M; Aydogdu S
    Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus-Induced Autoimmune Hemolytic Anemia in a Previously Reported Child With History of Thrombocytopenia Following Liver Transplant.
    Kaya Z; Egritas O; Dalgic B
    Exp Clin Transplant; 2018 Jun; 16(3):355-356. PubMed ID: 29633932
    [No Abstract]   [Full Text] [Related]  

  • 20. Tacrolimus and food allergy.
    Pacifico L; Frediani T; Simonetti A; Chiesa C; Cucchiara S
    Transplantation; 2003 Dec; 76(12):1778. PubMed ID: 14688538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.